D.E. Shaw & Co
DERM

D.E. Shaw & Co’s Dermira, Inc. DERM Stock Holding History

D.E. Shaw & Co’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,000
Closed -$92K – 4097
2018
Q2 		$92K Hold
10,000
– – ﹤0.01% 3621
2018
Q1 		$80K Buy
+10,000
New +$218K ﹤0.01% 3405

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co's DERM Position: Q1 2019 in Review

D.E. Shaw & Co sold out of Dermira, Inc. (DERM) in Q1 2019, closing a stake of 20,079 shares — an estimated $144K sold.

D.E. Shaw & Co first reported a position in DERM in Q4 2014 and held it in 16 quarters. The position peaked at $7.78M in Q4 2015. 144 funds tracked by Wall St. Rank hold DERM as of Q1 2019.

  • D.E. Shaw & Co reported no remaining Dermira, Inc. position as of Q1 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 20,079 Dermira, Inc. shares in Q1 2019, an estimated $144K.
  • D.E. Shaw & Co first reported a position in Dermira, Inc. in Q4 2014 and held it in 16 quarters.
  • D.E. Shaw & Co's Dermira, Inc. position peaked at $7.78M in Q4 2015.
  • 144 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.